Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Cancer Research|May 7, 2011
Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralizationGiorgia Nardo, Elena Favaro, Matteo Curtarello, et al.ESMO Open|May 30, 2020
<i>LKB1</i> mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trialClaudio Vernieri, Monica Ganzinelli, Eliana Rulli, et al.Frontiers in Oncology|April 21, 2025
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancerAlessandro Dal Maso, Federica Ferrarini, Giovanni Esposito, et al.Translational Lung Cancer Research|February 11, 2021
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcomeAlberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, et al.Cell Reports|January 19, 2017
Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1Ionica Masgras, Francesco Ciscato, Anna Maria Brunati, et al.Blood|May 10, 2011
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150Margherita Ghisi, Alberto Corradin, Katia Basso, et al.Clinical Lung Cancer|October 12, 2019
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non-small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid BiopsyAlessandro Dal Maso, Martina Lorenzi, Elisa Roca, et al.Journal of Neuro-Oncology|May 4, 2023
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumorsElisabetta Lazzarini, Domenico Alessandro Silvestris, Giuseppe Benvenuto, et al.Future Oncology (London, England)|May 14, 2021
Real-world data on treatment outcomes in <i>EGFR</i>-mutant non-small-cell lung cancer patients receiving osimertinib in second or further linesAlessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, et al.The Journal of Liquid Biopsy|March 3, 2025
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centersMichela Verzè, Andrea Boscolo Bragadin, Roberta Minari, et al.Pageof 16